Vail A, Gore S M, Bradley B A, Easty D L, Rogers C A, Armitage W J
University of Leeds, Institute of Epidemiology and Health Services Research.
Br J Ophthalmol. 1997 Aug;81(8):631-6. doi: 10.1136/bjo.81.8.631.
On the basis of finalised data from the Corneal Transplant Follow up Study to identify and quantify factors influencing corneal graft outcome in terms of graft survival, rejection, visual acuity, and astigmatism.
Multifactorial analysis of 2777 grafts registered by the UK Transplant Support Service from July 1987 to June 1991.
Several recipient factors influencing graft survival, rejection, and visual acuity were identified, but no donor factors. Of the operative factors amenable to change, mixed suturing was associated with reduced graft survival, and larger grafts with increased risk of rejection but better visual acuity when surviving. There was increased risk of rejection with poor matching at HLA class I antigens, but mismatched HLA-DR grafts suffered less rejection than those with zero HLA-DR mismatches. Recipient age below 10 years was associated with increased risk of both rejection and graft failure. However, whereas increasing age above 10 years was not associated with differential graft survival, it was significantly associated with decreasing risk of rejection.
While confirming possible benefits of HLA-A and B matching, the expense and delay involved in awaiting matched HLA-DR tissue is unlikely to be justified. Other donor factors are unrelated to graft outcome following screening of tissue by eye banks. The highest rates of graft failure and rejection happen in the early postoperative period, and factors influencing visual outcome are also apparent at this stage.
基于角膜移植随访研究的最终数据,从移植存活、排斥反应、视力和散光方面识别并量化影响角膜移植结果的因素。
对英国移植支持服务中心在1987年7月至1991年6月登记的2777例移植进行多因素分析。
确定了几个影响移植存活、排斥反应和视力的受体因素,但未发现供体因素。在可改变的手术因素中,混合缝合与移植存活率降低有关,较大的移植排斥风险增加,但存活时视力较好。HLA I类抗原匹配不佳时排斥风险增加,但HLA-DR错配的移植比HLA-DR无错配的移植排斥反应少。10岁以下的受体发生排斥反应和移植失败的风险增加。然而,虽然10岁以上年龄增长与移植存活率差异无关,但与排斥反应风险降低显著相关。
虽然证实了HLA-A和B匹配可能带来的益处,但等待匹配的HLA-DR组织所涉及的费用和延迟不太可能是合理的。眼库对组织进行筛查后,其他供体因素与移植结果无关。移植失败和排斥反应的最高发生率发生在术后早期,影响视力结果的因素在这个阶段也很明显。